This archive contains links to the full-text of all issues of Clin Mol Hepatol.
First decision
07 Days
Publication after acceptance
03 Days
*Last 12 months
Viewed By 6191 |
MAFLD: How is it different from NAFLD? |
Viewed By 5279 |
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma |
Viewed By 5005 |
Global incidence and prevalence of nonalcoholic fatty liver disease |
Viewed By 4169 |
Examining the therapeutic landscape of beta-blockers in portal hypertension |
Viewed By 3943 |
Gut microbiome and metabolome signatures in liver cirrhosis-related complications |
Cited By 272 |
Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma |
Cited By 225 |
Global incidence and prevalence of nonalcoholic fatty liver disease |
Cited By 155 |
MAFLD: How is it different from NAFLD? |
Cited By 79 |
Non-alcoholic fatty liver disease: Definition and subtypes |
Cited By 76 |
Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis |